Factors associated with the prevalence of antibiotic use for the treatment of hospital-acquired infections at 393 French hospitals: A regional variation analysis

Infection Control and Hospital Epidemiology

Volumn 32, Issue 2, 2011, Pages 155-162

  Amadeo, Brice ^a   Dumartin, C ^a,b   Venier, A G ^a,b   Fourrier Reglat A ^a,b   Coignard, B ^c   Rogues, A M ^a,b  

^a INSERM   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; LINCOSAMIDE; MACROLIDE; METRONIDAZOLE; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOGRAMIN DERIVATIVE; SULFONAMIDE; TRIMETHOPRIM; VANCOMYCIN;

ADULT; AGE; AGED; ARTICLE; BACTEREMIA; CATHETER INFECTION; DEMOGRAPHY; DRUG USE; EAR INFECTION; EYE INFECTION; FRANCE; HOSPITAL BED CAPACITY; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INTENSIVE CARE UNIT; INTRAVASCULAR CATHETER; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTILEVEL ANALYSIS; NOSE INFECTION; PHARYNGITIS; PNEUMONIA; PUBLIC HOSPITAL; RESPIRATORY TRACT INFECTION; SEPTICEMIA; SKIN INFECTION; SOFT TISSUE INFECTION; SURGICAL INFECTION; SURGICAL TECHNIQUE; TOTAL QUALITY MANAGEMENT; URINARY CATHETER; URINARY TRACT INFECTION;

AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CROSS INFECTION; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DRUG UTILIZATION; FRANCE; GEOGRAPHY; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE;

EID: 78751677962     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/657909     Document Type: Article

References (27)

1. Rogues AM, Placet-Thomazeau B, Parneix P, et al. Use of antibiotics in hospitals in south-western France. J Hosp Infect 2004;58:187-192. (Pubitemid 39462585)
2. Réseau d'alerte, d'investigation et de surveillance des infections nosocomiales (Raisin). Surveillance de la consommation des antibiotiques: Réseau ATB-Raisin - Résultats 2008. http://www.invs.sante.fr/ publications/2010/atb-raisin/rapport-atb-raisin.pdf. Accessed December 24, 2010.
3. Maugat D, Thiolet JM, L'Hériteau F, et al. Prévalence des traitements antibiotiques dans les établissements de santé, France. BEH 2007;51-52:432-437.
4. European Commission. Second report from the commission to the council on the basis of member states' reports on the implementation of the council recommendation (2002/77/EC) on the prudent use of antimicrobial agents in human medicine. Brussels: European Commission, 2010. http://www.ec.europa.eu/health/ antimicrobial-resistance/docs/amr-report2-en.pdf. Accessed July 5, 2010.
5. Desenclos JC. RAISIN - a national programme for early warning, investigation and surveillance of healthcare-associated infection in France. Euro Surveill 2009;14:piip19408. http://www.eurosurveillance.org/images/dynamic/ EE/V14N46/art19408.pdf. Accessed December 24, 2010.
6. Pan Z, Hu D. Multilevel analysis of individual and community predictors of smoking prevalence and frequency in China: 1991-2004. J Public Health Policy 2008;29:72-85.
7. Singer JD. Using SAS PROC MIXED to fit multilevel models, hierarchical models and individual growth models. J Educ Behav Stat 1998;24:323-355.
8. Twisk JWR. Applied multilevel analysis. New York, NY: Cambridge University Press, 2006.
9. Muller A, Mauny F, Talon D, et al. Effect of individual- and group-level antibiotic exposure on MRSA isolation: a multilevel analysis. J Antimicrob Chemother 2006;58:878-881.
10. Grammatico-Guillon L, Thiolet J-M, Bernillon P, et al. Relationship between the prevalence of methicillin-resistant Staphylococcus aureus infection and indicators of nosocomial infection control measures: a population-based study in French hospitals. Infect Control Hosp Epidemiol 2009;30:861-869.
11. Benoit SR, Nsa W, Richards CL, et al. Factors associated with antimicrobial use in nursing homes: a multilevel model. J Am Geriatr Soc 2008;56:2039-2044.
12. Amadeo B, Dumartin C, Robinson P, et al. Easily available adjustment criteria for the comparison of antibiotic consumption in a hospital setting: experience in France. Clin Microbiol Infect 2010;16:735-741.
13. Lee MK, Chiu CS, Chow VC, et al. Prevalence of hospital infection and antibiotic use at a university medical center in Hong Kong. J Hosp Infect 2007;65:341-347.
14. Ufer M, Radosevic N, Vogt A, et al. Antimicrobial drug use in hospitalised paediatric patients: a cross-national comparison between Germany and Croatia. Pharmacoepidemiol Drug Saf 2005;14:735-739.
15. Hajdu A, Samodova OV, Carlsson TR, et al. A point prevalence survey of hospital-acquired infections and antimicrobial use in a paediatric hospital in north-western Russia. J Hosp Infect 2007;66:378-384.
16. Usluer G, Ozgunes I, Leblebicioglu H. A multicenter pointprevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob 2005;4:16.
17. Gravel D, Taylor G, Ofner M, et al. Point prevalence survey for healthcare-associated infections within Canadian adult acute-care hospitals. J Hosp Infect 2007;66:243-248. (Pubitemid 46979842)
18. Pellizzer G, Mantoan P, Timillero L, et al. Prevalence and risk factors for nosocomial infections in hospitals of the Veneto region, north-eastern Italy. Infection 2008;36:112-119.
19. Seaton RA, Nathwani D, Burton P, et al. Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT). Int J Antimicrob Agents 2007;29:693-699.
20. Neuhauser MM, Weinstein RA, Rydman R, et al. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003;289:885-888.
21. Casey AL, Elliott TS. Progress in the prevention of surgical site infection. Curr Opin Infect Dis 2009;22:370-375.
22. Labeau SO, Vandijck DM, Rello J, et al. Centers for Disease Control and Prevention guidelines for preventing central venous catheter-related infection: results of a knowledge test among 3405 European intensive care nurses. Crit Care Med 2009;37:320-323.
23. Benko R, Matuz M, Doro P, et al. Hungarian hospital antibiotic consumption at the regional level, 1996-2005. Infection 2009;37:133-137.
24. Blix HS, Hartug S. Hospital usage of antibacterial agents in relation to size and type of hospital and geographical situation. Pharmacoepidemiol Drug Saf 2005;14:647-649.
25. de With K, Steib-Bauert M, Straach P, et al. Is there significant regional variation in hospital antibiotic consumption in Germany? Infection 2006;34:274-277. (Pubitemid 44563986)
26. Carlet J, Astagneau P, Brun-Buisson C, et al. French national program for prevention of healthcare-associated infections and antimicrobial resistance, 1992-2008: positive trends, but perseverance needed. Infect Control Hosp Epidemiol 2009;30:737-745.
27. Ansari F, Erntell M, Goossens H, et al. The European Surveillance of Antimicrobial Consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis 2009;49:1496-1504.